Medical team

Dr. Slavisa Tubin

Specialist doctor in radiooncology, director for clinical radiobiology & scientific co-director

Areas of expertise

  • Malignancies of the thorax
  • ENT
  • Skull base
  • Non-resectable “bulky”/large tumours
  • Oligometastatic tumours

Languages

English, German, Serbian, Croatian, Italian

Education

2008 – 2012

Specialist in radiooncology, Medical University of Rome, “La Sapienza”, Italy

2010 – 2011

Clinical research on breast and prostate cancer, Sylvester Comprehensive Cancer Centre/Jackson Memorial Hospital, University of Miami, Florida, USA

2010 – 2011

Experimental IN VITRO and IN VIVO research on lung cancer cells, Sylvester Comprehensive Cancer Centre, University of Miami, Florida, USA

2000 – 2006

Medical studies, Medical University of Rome “La Sapienza”, “Italy

Professional career

Since 2020

Specialist doctor in radiooncology, director for clinical radiobiology & scientific co-director at MedAustron

2015 – 2020

Senior physician at the Institute for Radiotherapy and Radiooncology, Clinic Klagenfurt KABEG, 9020 Klagenfurt, Austria

2012 – 2015

Senior physician and clinical research, Institute for Clinical Research “ECOMEDICA”-Empoli: Radiooncology Department, Florence, Italy

2010 – 2011

Clinical research, University of Miami Florida, USA

2008 – 2012

Specialist doctor in radiooncology, Sant’ Andrea Hospital: Radiooncology Department, University of Rome “La Sapienza”, Italy

2007 – 2008

Doctor, Oncological Hospice “Villa Speranza” – “Agostino Gemelli” University Polyclinic: palliative care, Rome, Italy

Memberships

Member of ÖGRO (Austrian Society for Radiooncology, Radiobiology and Medical Radiophysics)

Member of ESTRO (European Society for Radiotherapy and Oncology)

Member of ASTRO (American Society for Radiooncology)

Member of AIRO (Italian Association of Radiotherapy and Clinical Oncology)

Member of PTCOG (Particle Therapy Co-Operative Group)

Member of RSS (The Radiosurgery Society)

Selected publications

2019

Tubin S, Ashdown M, Jeremic B. “Time-synchronized immune-guided SBRT partial bulky tumor irradiation targeting hypoxic segment while sparing the peritumoral immune microenvironment.” Radiat Oncol. 2019 Dec 4;14(1):220. doi: 10.1186/s13014-019-1423-9.

2019

Tubin S, Gupta S, Grusch M, Popper HH, Brcic L, Ashdown ML, Khleif SN, Peter-Vörösmarty B, Hyden M, Negrini S, Fossati P, Hug E. Shifting the Immune-Suppressive to Predominant Immune-Stimulatory Radiation Effects by SBRT-PArtial Tumor Irradiation Targeting HYpoxic Segment (SBRT-PATHY). Cancers. 2021; 13(1):50. https://doi.org/10.3390/cancers13010050

2019

Tubin S., Popper H., Brcic L., „NOVEL STEREOTACTIC BODY RADIATION THERAPY (SBRT)-BASED PARTIAL TUMOR IRRADIATION TARGETING HYPOXIC SEGMENT OF BULKY TUMORS (SBRT-PATHY): IMPROVEMENT OF THE RADIOTHERAPY OUTCOME BY EXPLOITING THE BYSTANDER AND ABSCOPAL EFFECTS. Radiat Oncol. 2019 Jan 29;14(1):21. doi: 10.1186/s13014-019-1227-y.

2017

Tubin S., Mansoor M. A., Seema G., “Radiation and Hypoxia-Induced Non-Targeted Effects in Normoxic and Hypoxic Conditions in Human Lung Cancer Cells.” IJRB

2017

Tubin S., Raunik W., „Hunting for Abscopal and Bystander Effects: Clinical Exploitation of Non-Targeted Effects Induced by Partial High-Single-Dose Irradiation of the Hypoxic Tumour Segment in Oligometastatic Patients”, Acta Onc.

Contact us

Do you have any questions about ion beam therapy or MedAustron?

Do you have any questions about the therapy or procedure? Whatever you want to know, do not hesitate to contact us. We will get back to you within two business days.

Contakt Therapy request